Designed by me @ SCORE Communication
ERBITUX® is a monoclonal antibody. It is a targeted benefits substance (‘ targeted therapy ‘). It can to a cancer cell fixed sit down and these thereby defusing. Doctors prescribe it for certain types of cancer in the intestines (colorectal cancer) or in the mouth, throat and larynx (head and neck).
SCORE provides the Communication strategy and communications for Erbitux®. All traditional forms of communication are used. The relatively small medical audience is easy to reach intensively.
- Graphic Design